Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.7B | 2.8B | 2.3B | 2.6B |
Cost of revenue | 1.7B | 1.8B | 1.5B | 1.6B |
Gross profit | 1.0B | 1.0B | 874M | 973M |
Operating expense | ||||
Research & development | 15M | 15M | 20M | 18M |
Selling general and admin | 781M | 801M | 743M | 775M |
Other operating expenses | -7M | -1M | -3M | -12M |
Operating income | 235M | 229M | 114M | 192M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 172M | 150M | 42M | 113M |
Tax provision | 52M | 56M | 17M | 41M |
Net income | 120M | 94M | 25M | 72M |
Basic EPS | 1.0 | 0.8 | 0.2 | 0.6 |
Diluted EPS | 1.0 | 0.8 | 0.2 | 0.6 |
Basic average shares | 121.9M | 121.9M | 121.9M | 121.9M |
Diluted average shares | 121.9M | 121.9M | 121.9M | 121.9M |
EBITDA | 235M | 229M | 114M | 192M |
Net income from continuing op. | 172M | 150M | 42M | 113M |
Minority interests | -1M | 0 | -1M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |